Liver Diseases, Alcoholic
"Liver Diseases, Alcoholic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.
Descriptor ID |
D008108
|
MeSH Number(s) |
C06.552.645 C25.775.100.087.645
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Liver Diseases, Alcoholic".
Below are MeSH descriptors whose meaning is more specific than "Liver Diseases, Alcoholic".
This graph shows the total number of publications written about "Liver Diseases, Alcoholic" by people in this website by year, and whether "Liver Diseases, Alcoholic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2007 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2016 | 1 | 2 | 3 |
2017 | 1 | 0 | 1 |
2018 | 3 | 0 | 3 |
2019 | 8 | 1 | 9 |
2020 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
2022 | 1 | 0 | 1 |
2023 | 5 | 0 | 5 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Diseases, Alcoholic" by people in Profiles.
-
In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis. Sci Transl Med. 2024 Aug 07; 16(759):eadg1915.
-
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement. Nat Rev Gastroenterol Hepatol. 2024 Sep; 21(9):626-645.
-
Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records. Dig Dis Sci. 2023 12; 68(12):4474-4484.
-
Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study. Hepatol Commun. 2023 10 01; 7(10).
-
Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology. Nat Rev Gastroenterol Hepatol. 2023 Dec; 20(12):797-809.
-
Posttransplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic. Liver Transpl. 2023 07 01; 29(7):777-780.
-
Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005.
-
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States. Clin Gastroenterol Hepatol. 2022 10; 20(10):2307-2316.e3.
-
Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
-
Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut. 2022 01; 71(1):148-155.